Global Cannabis-based Medicines Market Size, Status and Forecast 2023-2027

Report ID: 951495 | Published Date: Sep 2024 | No. of Page: 97 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cannabis-based Medicines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 CBD (Cannabidiol) Based
        1.2.3 THC (Tetrahydrocannabinol) Based
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Cannabis-based Medicines Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Oral Solution
        1.3.3 Tablets
        1.3.4 Patches
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cannabis-based Medicines Market Perspective (2016-2027)
    2.2 Cannabis-based Medicines Growth Trends by Regions
        2.2.1 Cannabis-based Medicines Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cannabis-based Medicines Historic Market Share by Regions (2016-2021)
        2.2.3 Cannabis-based Medicines Forecasted Market Size by Regions (2022-2027)
    2.3 Cannabis-based Medicines Industry Dynamic
        2.3.1 Cannabis-based Medicines Market Trends
        2.3.2 Cannabis-based Medicines Market Drivers
        2.3.3 Cannabis-based Medicines Market Challenges
        2.3.4 Cannabis-based Medicines Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cannabis-based Medicines Players by Revenue
        3.1.1 Global Top Cannabis-based Medicines Players by Revenue (2016-2021)
        3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2016-2021)
    3.2 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cannabis-based Medicines Revenue
    3.4 Global Cannabis-based Medicines Market Concentration Ratio
        3.4.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2020
    3.5 Cannabis-based Medicines Key Players Head office and Area Served
    3.6 Key Players Cannabis-based Medicines Product Solution and Service
    3.7 Date of Enter into Cannabis-based Medicines Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cannabis-based Medicines Breakdown Data by Type
    4.1 Global Cannabis-based Medicines Historic Market Size by Type (2016-2021)
    4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2022-2027)

5 Cannabis-based Medicines Breakdown Data by Application
    5.1 Global Cannabis-based Medicines Historic Market Size by Application (2016-2021)
    5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cannabis-based Medicines Market Size (2016-2027)
    6.2 North America Cannabis-based Medicines Market Size by Type
        6.2.1 North America Cannabis-based Medicines Market Size by Type (2016-2021)
        6.2.2 North America Cannabis-based Medicines Market Size by Type (2022-2027)
        6.2.3 North America Cannabis-based Medicines Market Size by Type (2016-2027)
    6.3 North America Cannabis-based Medicines Market Size by Application
        6.3.1 North America Cannabis-based Medicines Market Size by Application (2016-2021)
        6.3.2 North America Cannabis-based Medicines Market Size by Application (2022-2027)
        6.3.3 North America Cannabis-based Medicines Market Size by Application (2016-2027)
    6.4 North America Cannabis-based Medicines Market Size by Country
        6.4.1 North America Cannabis-based Medicines Market Size by Country (2016-2021)
        6.4.2 North America Cannabis-based Medicines Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cannabis-based Medicines Market Size (2016-2027)
    7.2 Europe Cannabis-based Medicines Market Size by Type
        7.2.1 Europe Cannabis-based Medicines Market Size by Type (2016-2021)
        7.2.2 Europe Cannabis-based Medicines Market Size by Type (2022-2027)
        7.2.3 Europe Cannabis-based Medicines Market Size by Type (2016-2027)
    7.3 Europe Cannabis-based Medicines Market Size by Application
        7.3.1 Europe Cannabis-based Medicines Market Size by Application (2016-2021)
        7.3.2 Europe Cannabis-based Medicines Market Size by Application (2022-2027)
        7.3.3 Europe Cannabis-based Medicines Market Size by Application (2016-2027)
    7.4 Europe Cannabis-based Medicines Market Size by Country
        7.4.1 Europe Cannabis-based Medicines Market Size by Country (2016-2021)
        7.4.2 Europe Cannabis-based Medicines Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cannabis-based Medicines Market Size (2016-2027)
    8.2 Asia-Pacific Cannabis-based Medicines Market Size by Type
        8.2.1 Asia-Pacific Cannabis-based Medicines Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cannabis-based Medicines Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cannabis-based Medicines Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cannabis-based Medicines Market Size by Application
        8.3.1 Asia-Pacific Cannabis-based Medicines Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cannabis-based Medicines Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cannabis-based Medicines Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cannabis-based Medicines Market Size by Region
        8.4.1 Asia-Pacific Cannabis-based Medicines Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cannabis-based Medicines Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cannabis-based Medicines Market Size (2016-2027)
    9.2 Latin America Cannabis-based Medicines Market Size by Type
        9.2.1 Latin America Cannabis-based Medicines Market Size by Type (2016-2021)
        9.2.2 Latin America Cannabis-based Medicines Market Size by Type (2022-2027)
        9.2.3 Latin America Cannabis-based Medicines Market Size by Type (2016-2027)
    9.3 Latin America Cannabis-based Medicines Market Size by Application
        9.3.1 Latin America Cannabis-based Medicines Market Size by Application (2016-2021)
        9.3.2 Latin America Cannabis-based Medicines Market Size by Application (2022-2027)
        9.3.3 Latin America Cannabis-based Medicines Market Size by Application (2016-2027)
    9.4 Latin America Cannabis-based Medicines Market Size by Country
        9.4.1 Latin America Cannabis-based Medicines Market Size by Country (2016-2021)
        9.4.2 Latin America Cannabis-based Medicines Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cannabis-based Medicines Market Size (2016-2027)
    10.2 Middle East & Africa Cannabis-based Medicines Market Size by Type
        10.2.1 Middle East & Africa Cannabis-based Medicines Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cannabis-based Medicines Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cannabis-based Medicines Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cannabis-based Medicines Market Size by Application
        10.3.1 Middle East & Africa Cannabis-based Medicines Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cannabis-based Medicines Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cannabis-based Medicines Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cannabis-based Medicines Market Size by Country
        10.4.1 Middle East & Africa Cannabis-based Medicines Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cannabis-based Medicines Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GW Pharmaceuticals plc
        11.1.1 GW Pharmaceuticals plc Company Details
        11.1.2 GW Pharmaceuticals plc Business Overview
        11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
        11.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2016-2021)
        11.1.5 GW Pharmaceuticals plc Recent Development
    11.2 INSYS Therapeutics
        11.2.1 INSYS Therapeutics Company Details
        11.2.2 INSYS Therapeutics Business Overview
        11.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
        11.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021)
        11.2.5 INSYS Therapeutics Recent Development
    11.3 Aequus Pharmaceuticals
        11.3.1 Aequus Pharmaceuticals Company Details
        11.3.2 Aequus Pharmaceuticals Business Overview
        11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
        11.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021)
        11.3.5 Aequus Pharmaceuticals Recent Development
    11.4 Axim Biotechnologies
        11.4.1 Axim Biotechnologies Company Details
        11.4.2 Axim Biotechnologies Business Overview
        11.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
        11.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2016-2021)
        11.4.5 Axim Biotechnologies Recent Development
    11.5 Revive Therapeutics
        11.5.1 Revive Therapeutics Company Details
        11.5.2 Revive Therapeutics Business Overview
        11.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
        11.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021)
        11.5.5 Revive Therapeutics Recent Development
    11.6 MGC Pharmaceuticals
        11.6.1 MGC Pharmaceuticals Company Details
        11.6.2 MGC Pharmaceuticals Business Overview
        11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
        11.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021)
        11.6.5 MGC Pharmaceuticals Recent Development
    11.7 ECHO Pharmaceuticals
        11.7.1 ECHO Pharmaceuticals Company Details
        11.7.2 ECHO Pharmaceuticals Business Overview
        11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
        11.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021)
        11.7.5 ECHO Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cannabis-based Medicines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of CBD (Cannabidiol) Based
    Table 3. Key Players of THC (Tetrahydrocannabinol) Based
    Table 4. Key Players of Others
    Table 5. Global Cannabis-based Medicines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Cannabis-based Medicines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Cannabis-based Medicines Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Cannabis-based Medicines Market Share by Regions (2016-2021)
    Table 9. Global Cannabis-based Medicines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Cannabis-based Medicines Market Share by Regions (2022-2027)
    Table 11. Cannabis-based Medicines Market Trends
    Table 12. Cannabis-based Medicines Market Drivers
    Table 13. Cannabis-based Medicines Market Challenges
    Table 14. Cannabis-based Medicines Market Restraints
    Table 15. Global Cannabis-based Medicines Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Cannabis-based Medicines Market Share by Players (2016-2021)
    Table 17. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2020)
    Table 18. Ranking of Global Top Cannabis-based Medicines Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Cannabis-based Medicines Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cannabis-based Medicines Product Solution and Service
    Table 22. Date of Enter into Cannabis-based Medicines Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Cannabis-based Medicines Revenue Market Share by Type (2016-2021)
    Table 26. Global Cannabis-based Medicines Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Cannabis-based Medicines Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Cannabis-based Medicines Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Cannabis-based Medicines Revenue Market Share by Application (2016-2021)
    Table 30. Global Cannabis-based Medicines Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Cannabis-based Medicines Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Cannabis-based Medicines Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Cannabis-based Medicines Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Cannabis-based Medicines Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Cannabis-based Medicines Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Cannabis-based Medicines Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Cannabis-based Medicines Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Cannabis-based Medicines Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Cannabis-based Medicines Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. GW Pharmaceuticals plc Company Details
    Table 63. GW Pharmaceuticals plc Business Overview
    Table 64. GW Pharmaceuticals plc Cannabis-based Medicines Product
    Table 65. GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
    Table 66. GW Pharmaceuticals plc Recent Development
    Table 67. INSYS Therapeutics Company Details
    Table 68. INSYS Therapeutics Business Overview
    Table 69. INSYS Therapeutics Cannabis-based Medicines Product
    Table 70. INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
    Table 71. INSYS Therapeutics Recent Development
    Table 72. Aequus Pharmaceuticals Company Details
    Table 73. Aequus Pharmaceuticals Business Overview
    Table 74. Aequus Pharmaceuticals Cannabis-based Medicines Product
    Table 75. Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
    Table 76. Aequus Pharmaceuticals Recent Development
    Table 77. Axim Biotechnologies Company Details
    Table 78. Axim Biotechnologies Business Overview
    Table 79. Axim Biotechnologies Cannabis-based Medicines Product
    Table 80. Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
    Table 81. Axim Biotechnologies Recent Development
    Table 82. Revive Therapeutics Company Details
    Table 83. Revive Therapeutics Business Overview
    Table 84. Revive Therapeutics Cannabis-based Medicines Product
    Table 85. Revive Therapeutics Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
    Table 86. Revive Therapeutics Recent Development
    Table 87. MGC Pharmaceuticals Company Details
    Table 88. MGC Pharmaceuticals Business Overview
    Table 89. MGC Pharmaceuticals Cannabis-based Medicines Product
    Table 90. MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
    Table 91. MGC Pharmaceuticals Recent Development
    Table 92. ECHO Pharmaceuticals Company Details
    Table 93. ECHO Pharmaceuticals Business Overview
    Table 94. ECHO Pharmaceuticals Cannabis-based Medicines Product
    Table 95. ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2016-2021) & (US$ Million)
    Table 96. ECHO Pharmaceuticals Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cannabis-based Medicines Market Share by Type: 2020 VS 2027
    Figure 2. CBD (Cannabidiol) Based Features
    Figure 3. THC (Tetrahydrocannabinol) Based Features
    Figure 4. Others Features
    Figure 5. Global Cannabis-based Medicines Market Share by Application: 2020 VS 2027
    Figure 6. Oral Solution Case Studies
    Figure 7. Tablets Case Studies
    Figure 8. Patches Case Studies
    Figure 9. Others Case Studies
    Figure 10. Cannabis-based Medicines Report Years Considered
    Figure 11. Global Cannabis-based Medicines Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Cannabis-based Medicines Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Cannabis-based Medicines Market Share by Regions: 2020 VS 2027
    Figure 14. Global Cannabis-based Medicines Market Share by Regions (2022-2027)
    Figure 15. Global Cannabis-based Medicines Market Share by Players in 2020
    Figure 16. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cannabis-based Medicines as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2020
    Figure 18. Global Cannabis-based Medicines Revenue Market Share by Type (2016-2021)
    Figure 19. Global Cannabis-based Medicines Revenue Market Share by Type (2022-2027)
    Figure 20. North America Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Cannabis-based Medicines Market Share by Type (2016-2027)
    Figure 22. North America Cannabis-based Medicines Market Share by Application (2016-2027)
    Figure 23. North America Cannabis-based Medicines Market Share by Country (2016-2027)
    Figure 24. United States Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Cannabis-based Medicines Market Share by Type (2016-2027)
    Figure 28. Europe Cannabis-based Medicines Market Share by Application (2016-2027)
    Figure 29. Europe Cannabis-based Medicines Market Share by Country (2016-2027)
    Figure 30. Germany Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Cannabis-based Medicines Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Cannabis-based Medicines Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Cannabis-based Medicines Market Share by Region (2016-2027)
    Figure 40. China Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Cannabis-based Medicines Market Share by Type (2016-2027)
    Figure 48. Latin America Cannabis-based Medicines Market Share by Application (2016-2027)
    Figure 49. Latin America Cannabis-based Medicines Market Share by Country (2016-2027)
    Figure 50. Mexico Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Cannabis-based Medicines Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Cannabis-based Medicines Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Cannabis-based Medicines Market Share by Country (2016-2027)
    Figure 56. Turkey Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Cannabis-based Medicines Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. GW Pharmaceuticals plc Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
    Figure 60. INSYS Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
    Figure 61. Aequus Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
    Figure 62. Axim Biotechnologies Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
    Figure 63. Revive Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
    Figure 64. MGC Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
    Figure 65. ECHO Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2016-2021)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Frequently Asked Questions
Cannabis-based Medicines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cannabis-based Medicines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cannabis-based Medicines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Asthma Treatment

Asthma is an inflammatory disease of the airways to the lungs. It makes breathing difficult and c ... Read More